• 89,99 €

Description de l’éditeur

This book examines whether direct-to-consumer pharmaceutical advertising changed in response to recommendations made by the FDA in 2009 to enhance the informational and motivational value of advertising to be more accessible to minority populations and consequently work to reduce health disparities.

GENRE
Essais et sciences humaines
SORTIE
2018
31 août
LANGUE
EN
Anglais
LONGUEUR
140
Pages
ÉDITEUR
Lexington Books
TAILLE
5.7
Mo